Using Electronic Health Records from a Large Clinical Data Research Network to Understand Cancer Burden and Cancer Risks Among Transgender and Gender Nonconforming (TGNC) Individuals
使用来自大型临床数据研究网络的电子健康记录来了解跨性别者和性别不合格 (TGNC) 个体的癌症负担和癌症风险
基本信息
- 批准号:10056679
- 负责人:
- 金额:$ 39.21万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-08-01 至 2024-01-31
- 项目状态:已结题
- 来源:
- 关键词:AdoptionAgeAgingAlcohol consumptionAlcohol or Other Drugs useAlcoholsBehavioralCancer BurdenCaringCause of DeathChronicClinicalClinical DataClinical ResearchCohort AnalysisCohort StudiesCoinCountyDataData SetData SourcesDevelopmentDiagnosisDiscriminationDiseaseEconomicsElectronic Health RecordFaceFloridaFundingFutureGenderGender IdentityGoldHealthHealth behaviorHormone useHospitalsHuman Papilloma Virus-Related Malignant NeoplasmHuman PapillomavirusIncidenceIndividualInformation RetrievalKnowledgeLiteratureLogistic ModelsMachine LearningMalignant NeoplasmsManualsMedicalMental HealthMethodsMinority GroupsModelingMonitorNatural Language ProcessingOutcomePatientsPerformancePharmaceutical PreparationsPhysiciansPopulationProceduresReportingResearchResearch PriorityRiskRisk BehaviorsRisk FactorsScreening for cancerSex BehaviorSexual and Gender MinoritiesSexually Transmitted DiseasesSourceStructureSubstance abuse problemSurveysSystemTobaccoTobacco useUnited StatesWorkage relatedaging populationbasecancer riskcancer statisticscancer typeclinical practicecohortcomorbiditycomputable phenotypesdata registrydeep learningdemographicsevidence basegender nonconforminghealth care service organizationhealth service usehigh riskinformatics toolmalignant breast neoplasmneoplasm registryphenotyping algorithmpopulation basedprogramsrecruitscreening programsocialsocial exclusionsocial stigmastemstructured datastudy populationtransgender
项目摘要
ABSTRACT
Transgender and gender nonconforming (TGNC) people face a disproportionate burden of adverse health
outcomes. Although there is a growing body of literature on the unique health issues among TGNC
populations, they remain severely underserved as existing data on TGNC health are scarce. Under-reporting
is common due to issues related to social and economic marginalization, stigma, and discrimination, leading to
challenges in obtaining population-based estimates since TGNC individuals are often unwilling to self-identify
and reluctant to participate in traditional surveys. Further, past TGNC research has primarily focused on
mental health, substance use and abuse, and sexual transmitted infections and diseases. There is limited data
available on age-related chronic conditions such as cancer, the second leading cause of death in the United
States. Nonetheless, cancer is one of the top research priorities among the TGNC population. With a rapidly
growing aging TGNC population, there is an urgent need to characterize the cancer burden among these
individuals and understand how cancer impact them differentially compared to non-TGNC individuals. On the
other hand, rapid adoption of electronic health record (EHR) systems has made longitudinal clinical data
available for research. EHRs contain not only important structured data, such as demographics, diagnoses,
procedures, and medications, but also unstructured clinical narratives such as physician’s notes. More than 80
percent of the clinical information is documented in clinical narratives, which contain more detailed patient
information including gender identity and cancer risk factors. Motivated by these observations and built upon
our previous studies on 1) the adequacy of TGNC gender identity terms, 2) clinical natural language
processing methods for information extraction, and 3) EHR-based cohort studies, we propose to conduct a
population-based cohort analysis to examine the cancer burden and risk factors among TGNC people using a
unique data source from a large network of EHRs—OneFlorida, one of the 13 PCORI-funded clinical data
research networks (CDRNs) contributing to the PCORnet. Using both structured and unstructured OneFlorida
data, we will first develop computable phenotypes to identify TGNC individuals and subsequently evaluate their
cancer risk. Our research is significant because: 1) no population-based cohort studies on cancer risk have
been conducted among the TGNC population. Our results will support the development of tailored, evidence-
based cancer screening programs for TGNC people; 2) our research will create a cohort of TGNC people that
can be not only tracked longitudinally in EHR but also recruited for future clinical studies; and 3) working with a
PCORnet CDRN makes our analysis framework generalizable to the overall PCORNet. Overall, the proposed
research will advance our knowledge in cancer among the aging TGNC population.
摘要
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jiang Bian其他文献
Jiang Bian的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jiang Bian', 18)}}的其他基金
ACTS (AD Clinical Trial Simulation): Developing Advanced Informatics Approaches for an Alzheimer's Disease Clinical Trial Simulation System
ACTS(AD 临床试验模拟):为阿尔茨海默病临床试验模拟系统开发先进的信息学方法
- 批准号:
10753675 - 财政年份:2023
- 资助金额:
$ 39.21万 - 项目类别:
Disparities of Alzheimer's disease progression in sexual and gender minorities
性少数群体中阿尔茨海默病进展的差异
- 批准号:
10590413 - 财政年份:2023
- 资助金额:
$ 39.21万 - 项目类别:
Post-Acute Sequelae of SARS-CoV-2 Infection and Subsequent Disease Progression in Individuals with AD/ADRD: Influence of the Social and Environmental Determinants of Health
AD/ADRD 患者 SARS-CoV-2 感染的急性后遗症和随后的疾病进展:健康的社会和环境决定因素的影响
- 批准号:
10751275 - 财政年份:2023
- 资助金额:
$ 39.21万 - 项目类别:
Artificial Intelligence and Counterfactually Actionable Responses to End HIV (AI-CARE-HIV)
人工智能和反事实可行的终结艾滋病毒应对措施 (AI-CARE-HIV)
- 批准号:
10699171 - 财政年份:2023
- 资助金额:
$ 39.21万 - 项目类别:
An end-to-end informatics framework to study Multiple Chronic Conditions (MCC)'s impact on Alzheimer's disease using harmonized electronic health records
使用统一的电子健康记录研究多种慢性病 (MCC) 对阿尔茨海默病的影响的端到端信息学框架
- 批准号:
10728800 - 财政年份:2023
- 资助金额:
$ 39.21万 - 项目类别:
AI-ADRD: Accelerating interventions of AD/ADRD via Machine learning methods
AI-ADRD:通过机器学习方法加速 AD/ADRD 干预
- 批准号:
10682237 - 财政年份:2023
- 资助金额:
$ 39.21万 - 项目类别:
Advancing Precision Lung Cancer Surveillance and Outcomes in Diverse Populations (PLuS2)
推进不同人群的精准肺癌监测和结果 (PLuS2)
- 批准号:
10752848 - 财政年份:2023
- 资助金额:
$ 39.21万 - 项目类别:
Eligibility criteria design for Alzheimer's trials with real-world data and explainable AI
利用真实数据和可解释的人工智能设计阿尔茨海默病试验的资格标准
- 批准号:
10608470 - 财政年份:2023
- 资助金额:
$ 39.21万 - 项目类别:
Computational Drug Repurposing for AD/ADRD with Integrative Analysis of Real World Data and Biomedical Knowledge
通过对真实世界数据和生物医学知识的综合分析,计算药物再利用用于 AD/ADRD
- 批准号:
10576853 - 财政年份:2022
- 资助金额:
$ 39.21万 - 项目类别:
Computational Drug Repurposing for AD/ADRD with Integrative Analysis of Real World Data and Biomedical Knowledge
通过对真实世界数据和生物医学知识的综合分析,计算药物再利用用于 AD/ADRD
- 批准号:
10392169 - 财政年份:2022
- 资助金额:
$ 39.21万 - 项目类别:
相似国自然基金
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
- 批准号:JCZRQN202500010
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
- 批准号:2025JJ70209
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
- 批准号:2023JJ50274
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
- 批准号:n/a
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
- 批准号:81602908
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
- 批准号:81501928
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
The Phenomenon of Stem Cell Aging according to Methylation Estimates of Age After Hematopoietic Stem Cell Transplantation
根据造血干细胞移植后甲基化年龄估算干细胞衰老现象
- 批准号:
23K07844 - 财政年份:2023
- 资助金额:
$ 39.21万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Analysis of Age-dependent Functional Changes in Skeletal Muscle CB1 Receptors by an in Vitro Model of Aging-related Muscle Atrophy
通过衰老相关性肌肉萎缩的体外模型分析骨骼肌 CB1 受体的年龄依赖性功能变化
- 批准号:
22KJ2960 - 财政年份:2023
- 资助金额:
$ 39.21万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Joint U.S.-Japan Measures for Aging and Dementia Derived from the Prevention of Age-Related and Noise-induced Hearing Loss
美日针对预防与年龄相关和噪声引起的听力损失而导致的老龄化和痴呆症联合措施
- 批准号:
23KK0156 - 财政年份:2023
- 资助金额:
$ 39.21万 - 项目类别:
Fund for the Promotion of Joint International Research (International Collaborative Research)
The Effects of Muscle Fatigability on Gait Instability in Aging and Age-Related Falls Risk
肌肉疲劳对衰老步态不稳定性和年龄相关跌倒风险的影响
- 批准号:
10677409 - 财政年份:2023
- 资助金额:
$ 39.21万 - 项目类别:
Characterizing gut physiology by age, frailty, and sex: assessing the role of the aging gut in "inflamm-aging"
按年龄、虚弱和性别表征肠道生理学特征:评估衰老肠道在“炎症衰老”中的作用
- 批准号:
497927 - 财政年份:2023
- 资助金额:
$ 39.21万 - 项目类别:
Role of AGE/RAGEsignaling as a driver of pathological aging in the brain
AGE/RAGE信号传导作为大脑病理性衰老驱动因素的作用
- 批准号:
10836835 - 财政年份:2023
- 资助金额:
$ 39.21万 - 项目类别:
Deciphering the role of osteopontin in the aging eye and age-related macular degeneration
破译骨桥蛋白在眼睛老化和年龄相关性黄斑变性中的作用
- 批准号:
10679287 - 财政年份:2023
- 资助金额:
$ 39.21万 - 项目类别:
Elucidation of the protein kinase NLK-mediated aging mechanisms and treatment of age-related diseases
阐明蛋白激酶NLK介导的衰老机制及年龄相关疾病的治疗
- 批准号:
23K06378 - 财政年份:2023
- 资助金额:
$ 39.21万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Underlying mechanisms of age-related changes in ingestive behaviors: From the perspective of the aging brain and deterioration of the gustatory system.
与年龄相关的摄入行为变化的潜在机制:从大脑老化和味觉系统退化的角度来看。
- 批准号:
23K10845 - 财政年份:2023
- 资助金额:
$ 39.21万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Targeting Age-Activated Proinflammatory Chemokine Signaling by CCL2/11 to Enhance Skeletal Muscle Regeneration in Aging
通过 CCL2/11 靶向年龄激活的促炎趋化因子信号传导以增强衰老过程中的骨骼肌再生
- 批准号:
478877 - 财政年份:2023
- 资助金额:
$ 39.21万 - 项目类别:
Operating Grants